title: Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.
authors.affiliation: Department of Pathology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, the Netherlands.
authors.forename: A R
authors.initials: AR
authors.lastname: Nicolae-Cristea
authors.forename: M F
authors.initials: MF
authors.lastname: Benner
authors.forename: W H
authors.initials: WH
authors.lastname: Zoutman
authors.forename: R
authors.initials: R
authors.lastname: van Eijk
authors.forename: P M
authors.initials: PM
authors.lastname: Jansen
authors.forename: C P
authors.initials: CP
authors.lastname: Tensen
authors.forename: R
authors.initials: R
authors.lastname: Willemze
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002471:Cell Transformation, Neoplastic; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D019942:Genes, p16; D006801:Humans; D017730:Ki-1 Antigen; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000175:diagnosis* / Q000235:genetics; D011379:Prognosis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000235:genetics
chemical_list: C493966:CDKN2B protein, human; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16; D017730:Ki-1 Antigen